Rafael Holdings

RFL · NYSE

$1.29+$0.00 (+0.00%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $1.29

About RFL

Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 21 full-time employees. The company went IPO on 2018-03-12. The firm's segments include Healthcare, Infusion Technology and Real Estate. The Company’s lead candidate is Trappsol Cyclo, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder. The Healthcare segment comprises equity interests in LipoMedix Pharmaceuticals Ltd., Barer Institute Inc., Cornerstone Pharmaceuticals, Inc., Cyclo, and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which comprise a portion of one commercial building in Israel. The Infusion Technology segment comprises equity interests in Day Three Labs, Inc. LipoMedix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company.

Employees: 21
Headquarters: Newark, New Jersey
Listed: Mar 12, 2018
Sector: Health Care
Industry: Pharmaceuticals
Website: rafaelholdings.com

Leadership

Rafael Holdings executives
Name	Title	Since	Age
Howard Jonas	—	2017	69
N. Scott Fine	—	—	69
David Polinsky	—	—	54
Joshua Fine	—	—	43
Markus Sieger	—	—	60
Susan Bernstein	—	—	61
Alan Grayson	—	—	67
Mark Stein	—	—	54
Michael Weiss	—	—	74

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Rafael Holdings suppliers and customers
Company	Relationship	Country	Correlation
IDT B IDT	Customer	US	0.36
Genie Energy B GNE	Customer	US	0.11
Ono Pharmaceutical	Supplier and customer	JP	-0.60
Research Foundation of The State University of New York	Supplier and customer	US	—
Hebrew University of Jerusalem	Supplier and customer	IL	—

Similar companies

Companies in the same industry as Rafael Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.